Frontiers Forum Deep Dive series

Immune-mediated diseases and climate change

20 June 2024

Renowned researchers explored links between climate change and immune dysregulation, and solutions for reducing climate-related impacts on human health.


Speakers

  • Kari Nadeau

    Dr Kari Nadeau

    Harvard University, USA
    Read bio

  • Ioana Agache

    Prof Ioana Agache

    Transilvania University of Brasov, Romania
    Read bio

  • Prof Stephen Holgate

    Prof Stephen Holgate

    University of Southampton Faculty of Medicine, UK
    Read bio

  • Edward Maibach

    Prof Edward Maibach

    George Mason University, USA
    Read bio

  • John Balmes

    Dr John Balmes

    University of California San Francisco and Berkeley, USA
    Read bio

  • John Balbus

    Dr John Balbus

    U.S. Department of Health and Human Services, USA
    Read bio

Actions for reducing climate impacts on human health

The presentations and discussion in this Frontiers Forum Deep Dive session built on an article published in Frontiers in Science, describing how climate change is driving increases in asthma, allergies, cancers, and other immune-mediated diseases.  

The article authors and other experts outlined these links—and discussed the urgent need for equitable, multilevel solutions for minimizing environmental health hazards associated with climate change.

Session program


Introduction and setting the scene

Dr Kari Nadeau


Adaption and mitigation strategies to reduce climate impacts on immune health​

Prof Ioana Agache


Panel discussion and Q&A

Charting a path forward


Speaker and contributor bios

  • Kari Nadeau

    Chair of the Department of Environmental Health
    Harvard T.H. Chan School of Public Health, USA

    Dr Kari Nadeau’s pioneering work in allergy and immunology has significantly advanced our understanding of the environmental factors like air pollution, wildfires, and climate change affect the risk of developing allergies, asthma, and other immune disorders, especially in children. Her groundbreaking work in oral immunotherapy (OIT) has demonstrated that controlled exposure to allergens can induce desensitization in allergic individuals providing a potential pathway to reduce or eliminate severe allergic reactions.

    Kari is working with the WHO to develop policies for mitigating and adapting to environmental changes, especially wildland fires to create resiliency and co-benefits in communities. She is a member of the National Academy of Medicine and the U.S. EPA Children's Health Protection Committee.

  • Ioana Agache

    Professor of Allergy and Clinical Immunology
    Transilvania University of Brasov, Romania

    Prof Ioana Agache’s is a renowned expert in the field of asthma and allergy and clinical immunology. Her research explores asthma phenotypes and endotypes, biomarkers, immune modulation, AI/machine learning, and integrated management of allergic diseases, with a special focus on exposomics and One Health.

    She is Past President of the European Academy of Allergy and Clinical Immunology (EAACI) and led the development of their guidelines on the use of biologics in asthma and allergic diseases, on environmental science for allergy and asthma, and on allergic asthma. Prof. Agache's expertise is widely recognized, as evidenced by her role as the Deputy Editor of the European Journal of Allergy and Clinical Immunology.

  • Stephen Holgate

    Professor of Immunopharmacology
    University of Southampton Faculty of Medicine, UK

    Prof Sir Stephen Holgate’s pioneering research has profoundly impacted our understanding and treatment of allergic and respiratory diseases, including asthma, COPD and COVID-19. His research has informed guidelines on asthma management — including the role of mast cells and their mediators in asthma and allied disorders, the regulation and pharmacology of mast cells, and placing inflammation at the core of asthma pathophysiology. His work has informed international asthma management guidelines and validated therapeutic targets, improving patient care worldwide.

    His current research focuses on stratified medicine, the role of the epithelium in orchestrating asthma and the evolution of asthma across the life course. In 2020, he received a Knighthood for services to medical research.

  • Edward Maibach

    University Professor and Director of Mason’s Center for Climate Change Communication
    George Mason University, USA

    Prof Edward Maibach’s research centers on understanding and promoting public engagement in climate change. Previously, Ed served as Associate Director of the National Cancer Institute and as Worldwide Director of Social Marketing at Porter Novelli International.

    In 2021, news agency Thompson Reuters identified him as one of the world’s 10 most influential scientists working on climate change. He is a Member of the National Academy of Medicine and the Virginia Academy of Science, Engineering, and Medicine. In 2020, he was awarded the Beck Family Presidential Medal of Excellence in Research and Scholarship.

  • John Balmes

    Director, Northern California Center for Occupational and Environmental Health
    University of California San Francisco and Berkeley, USA

    Dr John Balmes’s research is dedicated to the respiratory, cardiovascular and metabolic health effects of various air pollutants and occupational agents.

    John collaborates on several epidemiological projects that are run out of the UC Berkeley School of Public Health, including the Children’s Health and Air Pollution Study (CHAPS). He also collaborates on studies of the effects of biomass smoke exposure on the respiratory health of children as well as respiratory and cardiovascular health of adults in rural Guatemala, Malawi, Rwanda, and Nepal. Currently, he is a member of the Nitrogen Oxides and Sulfur Oxides Review Panel of CASAC.

  • John Balbus

    Director, Office of Climate Change and Health Equity
    U.S. Department of Health and Human Services, USA

    Physician and public health professional Dr John Balbus specializes in the health implications of climate change and building healthy, sustainable, resilient communities and environment. Since joining the federal government in 2009, he has served as HHS Principal to the U.S. Global Change Research Program and co-chair of the working group on Climate Change and Human Health for the U.S. Global Change Research Program.

    John has also served as Senior Advisor for Public Health to the Director of the National Institute of Environmental Health Sciences. He was elected to the National Academy of Medicine in 2021..